Pale Fire Capital SE Has $16.74 Million Position in Teladoc Health, Inc. $TDOC

Pale Fire Capital SE cut its position in Teladoc Health, Inc. (NYSE:TDOC) by 41.9% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,973,762 shares of the health services provider’s stock after selling 1,424,729 shares during the quarter. Teladoc Health accounts for about 0.5% of Pale Fire Capital SE’s holdings, making the stock its 14th biggest holding. Pale Fire Capital SE owned about 1.09% of Teladoc Health worth $16,738,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of Teladoc Health by 2.8% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 193,714 shares of the health services provider’s stock worth $1,542,000 after acquiring an additional 5,235 shares during the last quarter. NewEdge Advisors LLC increased its position in Teladoc Health by 1,278.7% during the 1st quarter. NewEdge Advisors LLC now owns 11,305 shares of the health services provider’s stock valued at $90,000 after purchasing an additional 10,485 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in Teladoc Health by 5.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 447,992 shares of the health services provider’s stock worth $3,566,000 after purchasing an additional 24,124 shares during the last quarter. Acadian Asset Management LLC bought a new position in Teladoc Health during the 1st quarter worth approximately $615,000. Finally, Envestnet Asset Management Inc. acquired a new position in shares of Teladoc Health in the 2nd quarter worth approximately $89,000. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the stock. Citigroup lowered their target price on shares of Teladoc Health from $11.00 to $7.50 and set a “neutral” rating for the company in a research note on Monday, August 3rd. Bank of America boosted their price objective on Teladoc Health from $9.00 to $10.50 and gave the company a “buy” rating in a research note on Tuesday, July 7th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Teladoc Health in a research report on Wednesday, August 19th. Finally, Canaccord Genuity Group reduced their price target on shares of Teladoc Health from $11.00 to $10.00 and set a “buy” rating for the company in a report on Thursday, July 30th. Five equities research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $7.54.

Teladoc Health Stock Performance

Shares of NYSE TDOC opened at $6.46 on Thursday. The stock has a market cap of $1.17 billion, a price-to-earnings ratio of -6.53 and a beta of 2.12. Teladoc Health, Inc. has a fifty-two week low of $4.40 and a fifty-two week high of $9.89. The firm’s 50-day simple moving average is $7.86 and its 200 day simple moving average is $6.69.

Teladoc Health (NYSE:TDOC) last announced its earnings results on Wednesday, July 29th. The health services provider reported ($0.21) EPS for the quarter, beating the consensus estimate of ($0.25) by $0.04. The company had revenue of $606.93 million during the quarter, compared to the consensus estimate of $615.44 million. Teladoc Health had a negative net margin of 7.13% and a negative return on equity of 12.15%. The firm’s revenue for the quarter was down 4.0% on a year-over-year basis. During the same quarter in the prior year, the company posted ($0.19) earnings per share. Teladoc Health has set its Q3 2026 guidance at -0.300–0.200 EPS and its FY 2026 guidance at -1.000–0.750 EPS. On average, sell-side analysts predict that Teladoc Health, Inc. will post -0.89 EPS for the current year.

Teladoc Health Company Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.